Document:

<PAGE>

                                                                    EXHIBIT 10.1

                        MACE SECURITY INTERNATIONAL, INC.
             AMENDED AUDIT COMMITTEE CHARTER DATED NOVEMBER 3, 2005

I.    PURPOSE

      The purpose of the Audit Committee (the "Committee") is to oversee Mace
      Security International, Inc.'s (the "Company") accounting and financial
      reporting processes, the audits of the Company's financial statements, and
      the Company's internal controls. In so doing, the Committee should
      endeavor to maintain free and open means of communication between the
      members of the Committee, the other members of the Board of Directors (the
      "Board"), the independent auditors and the management of the Company.

      In the exercise of its oversight, it is not the duty of the Committee to
      plan or conduct audits or to determine that the Company's financial
      statements fairly present the Company's financial position and results of
      operations in accordance with generally accepted accounting principles.
      Instead, such duties remain under the oversight of management and the
      independent auditors.

II.   MEMBERSHIP

      The Committee shall be composed of three or more members of the Board. The
      members shall be appointed by action of the Board and shall serve at the
      discretion of the Board. Each Committee member shall be "financially
      literate" as determined by the Board in its business judgement and shall
      satisfy the "independence" requirements of the NASDAQ National Market. At
      least one member of the Committee shall have Accounting or related
      financial management expertise, as determined by the Board in its business
      judgement.

III.  COMMITTEE ORGANIZATION AND PROCEDURES

      A.    The members of the Committee shall appoint a Chair of the Committee
            by majority vote. The Chair (or in his or her absence, a member
            designated by the Chair) shall preside at all meetings of the
            Committee.

      B.    The Committee shall have the authority to establish its own rules
            and procedures consistent with the bylaws of the Company for notice
            and conduct of its meetings, should the Committee, in its
            discretion, deem it desirable to do so.

      C.    The Committee may, in its discretion, include in its meetings
            members of the Company's financial management, representatives of
            the independent auditors, and other financial personnel employed or
            retained by the Company. The Committee may meet with the independent
            auditors in separate executive sessions to discuss any matters that
            the Committee believes should be addressed privately, without
            management's presence. The Committee may likewise meet privately
            with management, as it deems appropriate.

      D.    The Committee may, at its discretion, utilize the services of the
            Company's regular corporate legal counsel with respect to legal
            matters or, at its discretion, retain outside legal counsel or other
            advisors if it determines that such counsel or advisors are
            necessary or appropriate under the circumstances.

IV.   KEY FUNCTIONS

      The Committee and the Board recognize that the Company's management is
      responsible for preparing the Company's financial statements and that the
      independent auditors are responsible for auditing those financial
      statements. Additionally, the Committee and the Board recognize that
      financial management, including the internal accounting staff, as well as
      the independent auditors, has more time and knowledge and more detailed
      information concerning the Company than do Committee members;
      consequently, in carrying out its responsibilities, the Committee is not
      providing any expert or special assurance as to the Company's financial
      statements or any professional certificate as to the independent auditors'
      work. It is not the duty of the

                                       i
<PAGE>

      Committee to plan or conduct audits or to determine whether the Company's
      financial statements are complete and accurate and are in accordance with
      generally accepted accounting principles.

      A.    OVERSIGHT RESPONSIBILITIES

            (i) The independent auditors shall be ultimately accountable to the
      Committee and the Board in connection with the audit of the Company's
      annual financial statements and related services. In this regard, the
      Committee shall be responsible for appointing, overseeing and periodically
      evaluating the performance of the auditors and, if necessary, terminating
      the independent auditors. As appropriate, the Committee shall recommend to
      the Board the submission of its selection of the independent auditors for
      stockholder ratification at any meeting of stockholders.

            (ii) The Committee shall approve the fees to be paid to the
      independent auditors and any other terms of the engagement of the
      independent auditors. The Chair (or in his or her absence, a member
      designated by the Chair) may represent the entire Committee for purposes
      of this discussion.

            (iii) The Committee shall receive from the independent auditors, at
      least annually, a written statement delineating all relationships between
      the independent auditors and the Company, consistent with Independence
      Standards Board Standard No. 1. The Committee shall actively engage in a
      dialogue with the independent auditors with respect to any disclosed
      relationships or services that, in the view of the Committee, may affect
      the objectivity and independence of the independent auditors. If the
      Committee determines that further inquiry is advisable, the Committee
      shall recommend that the Board take any appropriate action in response to
      the independent auditors' independence.

      B.    ANNUAL AUDIT

            (i) The Committee shall meet with the independent auditors, chief
      financial officer and other management personnel in connection with each
      annual audit to discuss the scope of the audit and the procedures to be
      followed. The Chair (or in his or her absence, a member designated by the
      Chair) may represent the entire Committee for purposes of this discussion.

            (ii) The Committee shall review(1) and discuss the audited financial
      statements with the management of the Company.

            (iii) The Committee shall discuss with the independent auditors the
      matters required to be discussed by Statement on Auditing Standards No. 61
      as then in effect including, among others: (1) the methods used to account
      for any significant unusual transaction reflected in the audited financial
      statements; (2) the effect of significant accounting policies in any
      controversial or emergent areas for which there is a lack of authoritative
      guidance or a consensus to be followed by the independent auditors; (3)
      the process used by management in

-------------------
(1) Auditing Literature, particularly, Statement on Auditing Standards No. 100,
defines the term "review" to include a particular set of required procedures to
be undertaken by independent accountants. The members of the Audit Committee are
not independent accountants, and the term "review" as used in this Amended Audit
Committee Charter is not intended to have this meaning. Consistent with footnote
47 of the SEC Release No. 34-42266, any use in this Amended Audit Committee
Charter of the term "review" should not be interpreted to suggest that the
Committee members can or should follow the procedures required of auditors
performing review of interim financial statements.

                                       ii
<PAGE>

      formulating particularly sensitive accounting estimates and the basis for
      the auditors' conclusions regarding the reasonableness of those estimates;
      and (4) any disagreements with management over the application of
      accounting principles, the basis for management's accounting estimates, or
      the disclosures in the financial statements.

            (iv) The Committee shall, based on the review and discussion in
      paragraph B(iii) above, and based on the disclosures received from the
      independent auditors regarding its independence and discussions with the
      auditors regarding such independence, conclude whether the audited
      financial statements should be included in the Company's Annual Report on
      Form 10-K for the fiscal year subject to the audit.

      C.    QUARTERLY REVIEW

            (i) The independent auditors are required to review the interim
      financial statements to be included in Form 10-Q of the Company using
      professional standards and procedures for conducting such reviews, as
      established by generally accepted auditing standards as modified or
      supplemented by the Securities and Exchange Commission, prior to the
      filing of the Form 10-Q. The Committee, in its discretion, may discuss
      with management and the independent auditors in person, at a meeting, or
      by conference telephone call, the results of the quarterly review
      including such matters as significant adjustments, management judgements,
      accounting estimates, significant new accounting policies and
      disagreements with management. The Chair (or in his or her absence, a
      member designated by the Chair) may represent the entire Committee for
      purposes of this discussion.

            (ii) The Committee shall review the Company's quarterly and annual
      financial statements with the Company's Chief Financial Officer before
      they are released publicly. The review of annual financial statements
      shall be conducted prior to publication.

      D.    INTERNAL CONTROLS

            (i) The Committee shall discuss with the independent auditors, at
      least annually, the adequacy and effectiveness of the accounting and
      financial controls of the Company, and consider any recommendations for
      improvement of such internal control procedures.

            (ii) The Committee shall discuss with the independent auditors and
      with management any letter of recommendation provided by the independent
      auditors and any other significant matters brought to the attention of the
      Committee by the independent auditors as a result of its annual audit. The
      Committee should allow management adequate time to consider any such
      matters raised by the independent auditors.

      E.    OTHER RESPONSIBILITIES

            (i) The Committee shall review and reassess the Committee's Charter
      at least annually and submit any recommended changes to the Board for its
      consideration.

            (ii) The Committee shall provide the report for inclusion in the
      Company's Annual Proxy Statement required by Item 306 of Regulation S-K of
      the Securities and Exchange Commission.

            (iii) The Committee, through its Chair, shall report periodically,
      as deemed necessary or desirable by the Committee, but at least annually,
      to the full Board regarding the Committee's actions and recommendations,
      if any.

            (iv) The Committee may institute investigations of suspected
      improprieties on any material matter selected by the Committee and is
      authorized to engage on behalf of the Company special counsel, independent
      auditors or outside experts when necessary.

            (v) The Committee shall annually disclose amounts received by Audit
      Committee members from the Company and its affiliates and any other
      transactions with the Company or its affiliates to which they are a party,
      other than amounts received for service as a Director or Board Committee
      member. Such disclosure shall be noted in the minutes of the appropriate
      Committee meeting.

                                      iii
<PAGE>

            (vi) The Committee shall annually review all existing related party
      transactions or other conflicts of interest that exist between
      employees/directors and the Company. The Committee shall review all
      proposed related party transactions. The Company shall not enter into any
      related party transactions unless first approved of by the Committee. The
      Committee may also make recommendations to the full Board of Directors on
      actions to be taken that relate to any proposed or existing related party
      transactions.

            (viii) The Committee shall determine the appropriate level of
      funding to be provided by the Company for payment of the independent
      auditor and outside advisors and any administrative expenses incurred by
      the Committee in carrying out its duties.

            (ix) The Committee shall establish, implement and oversee procedures
      for the receipt, retention and treatment of complaints regarding
      accounting, internal accounting controls or auditing matters and
      procedures for confidential, anonymous submissions by Company employees
      regarding questionable accounting or auditing matters.

      F.    MINUTES

            Minutes of each meeting will be compiled by the Company's Corporate
      Secretary who shall act as Secretary to the Committee, who is also a
      member of the Company's internal legal staff, or in the absence of the
      Corporate Secretary, by an Assistant Corporate Secretary of the Company,
      or any other person designated by the Committee.

                                       ivexv10w2

 

EXHIBIT 10.2

Safeguard Scientifics, Inc., a Pennsylvania corporation (the “Company”), hereby grants to the
grantee named below (“Grantee”) an option (this “Option”) to purchase the total number of shares
shown below of Common Stock of the Company (the “Shares”) at the exercise price per share set forth
below, as an inducement to accept employment with the Company pursuant to that certain employment
agreement between the Company and Grantee dated August 1, 2005 (the “Employment Agreement”),
subject to all of the terms and conditions on the subsequent pages of this Stock Option Grant
Certificate. Although the grant is not made pursuant to the 2004 Equity Compensation Plan (the
“Plan”), except as otherwise provided herein, the grant shall be subject to the rules of the Plan
as if it were a grant made pursuant to the Plan. Unless otherwise defined herein, capitalized
terms used herein shall have the meanings ascribed to them in the Plan. The terms and conditions
set forth on subsequent pages hereto and the terms and conditions of the Plan are incorporated
herein by reference. This Stock Option Grant Certificate shall constitute the “Agreement” for this
Option as such term is used in the Plan.

	 	 	 
	Grant Date:

	 	August 16, 2005
	 
	 	 
	Type of Option:

	 	Nonqualified Option
	 
	 	 
	Shares Subject to Option:

	 	3,000,000
	 
	 	 
	Exercise Price Per Share:

	 	$1.275
	 
	 	 
	Term of Option:

	 	8 years

Shares subject to issuance under this Option will vest solely as provided in Section 3 of this Stock Option Grant Certificate.

The Company shall have the right, without the consent of Grantee, to amend the terms of this Stock Option Grant Certificate to the extent necessary
or appropriate,

as determined by the Company in its sole discretion, to conform with Section 409A of the Internal Revenue Code of 1986, as amended.

Grantee hereby acknowledges receipt of a copy of the Plan, represents that Grantee has read the Plan and understands the terms and provisions of the
Plan, and accepts this Option as if it were granted pursuant to the Plan and subject to all the terms and conditions of the Plan and this Stock
Option Grant Certificate, except as otherwise provided herein. Grantee acknowledges that the grant and exercise of this Option, and the sale of
Shares obtained through the exercise of this Option, may have tax implications that could result in adverse tax consequences to the Grantee and that
Grantee is not relying on the Company for any tax, financial or legal advice and will consult a tax adviser prior to such exercise or disposition.

This Option is designated a nonqualified stock option. It is not an incentive stock option within the meaning of Section 422 of the Internal Revenue
Code of 1986, as amended (the “Code”).

In witness whereof, this Stock Option Grant Certificate has been executed by the Company by a duly authorized officer as of the date specified hereon.

	 
	Safeguard Scientifics, Inc.

	/s/ Christopher J. Davis

	 
Christopher J. Davis, Executive Vice President

	and Chief Administrative & Financial Officer

	 

	/s/ Peter J. Boni

	 
 Peter
J. Boni

 

 

1.      Option Expiration. The Option shall automatically terminate upon the happening of the
first of the following events:

          (a)      the expiration of the 90-day period after the Grantee ceases to be employed by, or
providing services to, the Company, if the termination is for any reason other than involuntary
termination without Cause or voluntary termination with Good Reason, Disability, death, Cause, a
Change of Control Termination or retirement as provided herein;

          (b)       the expiration of the one-year period after the Grantee ceases to be employed by, or
providing services to, the Company, on account of the Grantee’s involuntary termination without
Cause or voluntary termination with Good Reason (not including a Change of Control Termination);

          (c)      the expiration of the one-year period after the Grantee ceases to be employed by, or
providing services to, the Company on account of the Grantee’s Disability;

          (d)      the expiration of the one-year period after the Grantee ceases to be employed by, or
providing services to, the Company if the Grantee dies while employed by the Company or if the
Grantee dies within three months after the Grantee ceases to be so employed on account of a
termination described in subparagraph (a) above;

          (e)      the date on which the Grantee ceases to be employed by, or providing services to, the
Company for Cause;

          (f)      the expiration of the one-year period after the Grantee’s employment or service terminates
as a result of retirement on or after the Grantee’s sixty-fifth birthday, or after such earlier
date as may be determined by the Committee, in its sole discretion, to be warranted given the
particular circumstances surrounding the earlier termination of the Grantee’s employment or
service; or

          (g)      where there has been a Change of Control Termination, the three-year period after the
Grantee ceases to be employed by, or providing services to, the Company, on account of the Grantee
experiencing a Change of Control Termination.

          Notwithstanding the foregoing, in no event may the Option be exercised after the expiration of
the Term of Option specified on page 1. For purposes of this Option, the terms “Cause,” “Good
Reason,” “Disability” and “Change of Control Termination” shall have the meaning given to them in
the Employment Agreement. Other than as set forth in this Agreement, any portion of the Option that
is not vested at the time the Grantee ceases to be employed by, or providing service to, the
Company shall immediately terminate.

          In the event a Grantee ceases to be employed by, or providing service to, the Company for
Cause, the Grantee shall automatically forfeit all shares underlying any exercised portion of an
Option for which the Company has not yet delivered the share certificates upon refund by the
Company of the exercise price paid by the Grantee for such shares.

2.      Exercise Procedures.

          (a)      Subject to the provisions of this Stock Option Grant Certificate and the Plan, the Grantee
may exercise part or all of the vested Option by giving the Company written notice of intent to
exercise in the manner provided in Paragraph 12 below, specifying the number of Shares as to which
the Option is to be exercised. On the delivery date, the Grantee shall pay the exercise price (i)
in cash, (ii) by delivering Shares of the Company (duly endorsed for transfer or accompanied by
stock powers signed in blank) which shall be valued at their fair market value on the date of
delivery, or (iii) by such other method as the Committee may approve, including payment through a
broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board. The
Committee may impose from time to time such limitations as it deems appropriate on the use of
Shares of the Company to exercise the Option.

          (b)      The obligation of the Company to deliver Shares upon exercise of the Option shall be
subject to all applicable laws, rules, and regulations and such approvals by governmental agencies
as may be deemed appropriate by the Committee, including such actions as Company counsel shall deem
necessary or appropriate to comply with relevant securities laws and regulations. The Company may
require that the Grantee (or other person exercising the Option after the Grantee’s death)
represent that the Grantee is purchasing Shares for the Grantee’s own account and not with a view
to or for sale in connection with any distribution of the Shares, or such other representation as
the Board deems appropriate. All obligations of the Company under this Stock Option Grant
Certificate shall be subject to the rights of the Company as set forth in the Plan as if the grant
had been issued pursuant to the Plan, to withhold amounts required to be withheld for any taxes, if
applicable. Subject to Committee approval, the Grantee may elect to satisfy any income tax
withholding obligation of the Company with respect to the Option by having Shares withheld up to an
amount that does not exceed the minimum marginal tax rate for federal (including FICA), state and
local tax liabilities.

 

 

3.      Vesting and Forfeiture of Unvested Options.

         (a)      In the event of Grantee’s termination of employment for any reason, Grantee shall forfeit
all Options in which Grantee is not vested at the time of his cessation of service in accordance
with the Vesting Schedule set forth in Section 3(b) (hereinafter referred to as the “Unvested
Options”).

         (b)  (1)           Basic Vesting.

                If the Grantee remains actively employed by the Company through the applicable vesting events,
Grantee shall acquire a vested interest in, and the forfeiture provisions of this Section 3 shall
lapse, according to the following schedule:

               (i)      300,000 Options shall vest and become exercisable on the first date after the Grant Date
that the average Market Capitalization of the Company for the twenty (20) consecutive trading days
ending immediately prior to such date equals or exceeds $100,000,000 + Base Market Capitalization,
provided that the total number of Options that shall have vested under this Section 3(b) as of such
date shall not exceed 300,000.

                (ii)      An additional 600,000 Options shall vest and become exercisable on the first date after
the Grant Date that the average Market Capitalization of the Company for the twenty (20)
consecutive trading days ending immediately prior to such date equals or exceeds $250,000,000 +
Base Market Capitalization, provided that the total number of Options that shall have vested under
this Section 3(b) as of such date shall not exceed 900,000.

                (iii)      An additional 900,000 Options shall vest and become exercisable on the first date after
the Grant Date that the average Market Capitalization of the Company for the twenty (20)
consecutive trading days ending immediately prior to such date equals or exceeds $450,000,000 +
Base Market Capitalization, provided that the total number of Options that shall have vested under
this Section 3(b) as of such date shall not exceed 1,800,000.

                (iv)      An additional 1,200,000 Options shall vest and become exercisable on the first date after
the Grant Date that the average Market Capitalization of the Company for the twenty (20)
consecutive trading days ending immediately prior to such date equals or exceeds $700,000,000 +
Base Market Capitalization, provided that the total number of Options that shall have vested under
this Section 3(b) as of such date shall not exceed 3,000,000.

                (2)           Additional Vesting for Partial Achievement of Performance Goals.

               The purpose of this Section 3(b)(2) is to provide a mechanism to allow the vesting of Options
under circumstances where Market Capitalization during a semi-annual period exceeds the Base Market
Capitalization or one of the vesting thresholds in Section 3(b)(1)(i), (ii) or (iii) above, equal
to the pro rated portion of the additional Options that would vest and become exercisable upon the
satisfaction of the next higher vesting threshold that corresponds to the pro rated portion of the
incremental Market Capitalization performance target that is achieved during such semi-annual
period.

                As of the last day of each six-month period during the term of the Option beginning on the
Grant Date and each half-year anniversary thereof during which the Grantee has been continuously
employed by the Company (the “Test Period”), the Company shall determine the highest average Market
Capitalization of the Company for any twenty (20) consecutive trading days within such Test Period
(the “Test Market Capitalization”). Based on the Test Market Capitalization, as of the last day of
the Test Period, additional Options shall vest as follows (in each case, rounded to the nearest
whole Option):

                (i)      If the Test Market Capitalization is less than the Base Market Capitalization, no
additional Options shall vest and become exercisable.

               (ii)      If the Test Market Capitalization is greater than the Base Market Capitalization, but
less than $100,000,000 + Base Market Capitalization, an additional number of Options shall vest and
become exercisable, determined as the positive difference if any, of :

(A)      the product of 300,000 times a fraction, the numerator of which is the excess of the
Test Market Capitalization over the Base Market Capitalization, and the denominator of
which is $100,000,000, minus

(B)      the number of Options that have previously vested under this Section 3(b).

                (iii)      If the Test Market Capitalization is greater than $100,000,000 + Base Market
Capitalization, but less than $250,000,000 + Base Market Capitalization, an additional number of
Options shall vest and become exercisable, determined as the positive difference, if any, of

 

 

(A)      the sum of (I) 300,000 plus (II) the product of 600,000 times a fraction, the numerator
of which is the excess of the Test Market Capitalization over $100,000,000 + Base Market
Capitalization, and the denominator of which is $150,000,000, minus

(B)      the number of Options that have previously vested under this Section 3(b).

                (iv)      If the Test Market Capitalization is greater than $250,000,000 + Base Market
Capitalization, but less than $450,000,000 + Base Market Capitalization, an additional number of
Options shall vest and become exercisable, determined as the positive difference, if any, of

(A)      the sum of (I) 900,000 plus (II) the product of 900,000 times a fraction, the numerator
of which is the excess of the Test Market Capitalization over $250,000,000 + Base Market
Capitalization, and the denominator of which is $200,000,000, minus

(B)      the number of Options that have previously vested under this Section 3(b).

                (v)      If the Test Market Capitalization is greater than $450,000,000 + Base Market
Capitalization, but less than $700,000,000 + Base Market Capitalization, an additional number of
Options shall vest and become exercisable, determined as the positive difference, if any, of

(A)      the sum of (I) 1,800,000 plus (II) the product of 1,200,000 times a fraction, the
numerator of which is the excess of the Test Market Capitalization over $450,000,000 + Base
Market Capitalization, and the denominator of which is $250,000,000, minus

(B)      the number of Options that have previously vested under this Section 3(b).

                For purposes of this Section 3(b), “Market Capitalization” for a given date means (A) the per
share closing price of the Company’s common stock listed on the New York Stock Exchange, as
reported on the composite tape for transactions on the New York Stock Exchange (or if the Company’s
common stock is not principally traded on such exchange, the per share closing price of the common
stock on the Nasdaq National Market, as reported on the composite tape for transactions on the
Nasdaq National Market, or if the Company’s common stock is not principally traded on such market,
the mean between the last reported “bid” and “asked” prices of common stock on the relevant date,
as reported on Nasdaq or, if not so reported, as reported by the National Daily Quotation Bureau,
Inc. or as reported in a customary financial reporting service, as applicable and as the Board
determines; if the Company’s common stock is not publicly traded or, if publicly traded, is not
subject to reported transactions or “bid” or “asked” quotations as set forth above, the price per
share shall be as determined by the Board in its sole and absolute discretion); multiplied by (B)
the total outstanding shares, together with all outstanding options to acquire shares of common
stock, as of August 16, 2005, which equals 134,064,824. In the event of any changes in the number
or kind of shares of common stock outstanding by reason of a stock dividend, spinoff,
recapitalization, stock split or combination or exchange of shares, the number of outstanding
shares set forth in the preceding sentence shall be adjusted appropriately to reflect such changes.

                The term “Base Market Capitalization” shall mean $172,943,623, which is calculated on the
basis of the total outstanding shares of common stock, together with all outstanding options to
acquire common stock, as of August 16, 2005 multiplied by the average per share closing price
(determined in the manner set forth in the preceding paragraph) for the twenty (20) consecutive
trading days immediately preceding the date the Company issued a press release announcing the
appointment of the Grantee as the Company’s President and Chief Executive Officer.

Notwithstanding the foregoing, in the event of a “Change of Control,” as such term is defined in
the Employment Agreement, the Grantee shall be deemed to be fully vested in any Unvested Options.

4.      Change of Control. The provisions of the Employment Agreement and this Stock Option
Grant Certificate relating to Change of Control and Change of Control Termination shall override
any provisions of the Plan relating to Change of Control.

5.      Restrictions on Exercise. Only the Grantee may exercise the Option during the Grantee’s
lifetime. After the Grantee’s death, the Option shall be exercisable (subject to the limitations
specified in the Plan) solely by the legal representatives of the Grantee, or by the person who
acquires the right to exercise the Option by will or by the laws of descent and distribution, to
the extent that the Option is exercisable pursuant to this Stock Option Grant Certificate.
Notwithstanding the foregoing, the Committee may provide, at or after grant, that a Grantee may
transfer nonqualified stock options pursuant to a domestic relations order or to family members or
other persons or entities on such terms as the Committee may determine.

 

 

6.      Grant Subject to Plan Provisions; Entire Agreement. This grant is made separate from
the Plan, as an inducement to Grantee to accept employment pursuant to the Employment Agreement.
Notwithstanding the preceding sentence, except to the extent otherwise stated in this Stock Option
Grant Certificate or to the extent the context otherwise requires, this grant shall be interpreted
as if it had been granted pursuant to the Plan. The grant and exercise of the Option shall be
subject to the provisions of the Plan and to interpretations, regulations and determinations
concerning the Plan established from time to time by the Committee in accordance with the
provisions of the Plan, including, but not limited to, provisions pertaining to (i) rights and
obligations with respect to withholding taxes, (ii) the registration, qualification or listing of
the Shares, (iii) capital or other changes of the Company, and (iv) other requirements of
applicable law, all as if the grant had been made pursuant to the Plan. The Committee shall have
the authority to interpret and construe the Option as if it had been granted pursuant to the terms
of the Plan, and its decisions shall be conclusive as to any questions arising hereunder. This
Stock Option Grant Certificate represents the entire agreement between the parties with respect to
the grant of the Option and may only be modified or amended in a writing signed by both parties.

7.      No Employment Rights. The grant of the Option shall not confer upon the Grantee any
right to be retained by or in the employ of the Company and shall not interfere in any way with the
right of the Company to terminate the Grantee’s employment or service at any time pursuant to the
Employment Agreement. No policies, procedures or statements of any nature by or on behalf of the
Company (whether written or oral, and whether or not contained in any formal employee manual or
handbook) shall be construed to modify this Stock Option Grant Certificate or to create express or
implied obligations to the Grantee of any nature.

8.      No Stockholder Rights. Neither the Grantee, nor any person entitled to exercise the
Grantee’s rights in the event of the Grantee’s death, shall have any of the rights and privileges
of a stockholder with respect to the Shares subject to the Option until certificates for Shares
have been issued upon the exercise of the Option.

9.      No Disclosure. The Grantee acknowledges that the Company has no duty to disclose to the
Grantee any material information regarding the business of the Company or affecting the value of
the Shares before or at the time of a termination of the Grantee’s employment, including without
limitation any plans regarding a public offering or merger involving the Company.

10.    Assignment and Transfers. The rights and interests of the Grantee under this Stock
Option Grant Certificate may not be sold, assigned, encumbered or otherwise transferred except, in
the event of the death of the Grantee, by will or by the laws of descent and distribution. In the
event of any attempt by the Grantee to alienate, assign, pledge, hypothecate, or otherwise dispose
of the Option or any right hereunder, except as provided for in this Stock Option Grant
Certificate, or in the event of the levy or any attachment, execution or similar process upon the
rights or interests hereby conferred, the Company may terminate the Option by notice to the
Grantee, and the Option and all rights hereunder shall thereupon become null and void. The rights
and protections of the Company hereunder shall extend to any successors or assigns of the Company
and to the Company’s parents, subsidiaries, and affiliates. This Stock Option Grant Certificate
may be assigned by the Company without the Grantee’s consent.

11.    Applicable Law. The validity, construction, interpretation and effect of this
instrument shall be governed by and determined in accordance with the laws of the Commonwealth of
Pennsylvania.

12.    Notice. Any notice to the Company provided for in this instrument shall be addressed
to the Company in care of the General Counsel at the Company’s headquarters and any notice to the
Grantee shall be addressed to such Grantee at the current address shown on the payroll of the
Company, or to such other address as the Grantee may designate to the Company in writing. Any
notice shall be delivered by hand, sent by telecopy or enclosed in a properly sealed envelope
addressed as stated above, registered and deposited, postage prepaid, in a post office regularly
maintained by the United States Postal Service.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}]]